Michael Kelly, | |
166 Kinsley St Ste 201, Nashua, NH 03060 | |
(603) 880-9177 | |
(603) 880-9672 |
Full Name | Michael Kelly |
---|---|
Gender | Male |
Speciality | Podiatry |
Experience | 9 Years |
Location | 166 Kinsley St Ste 201, Nashua, New Hampshire |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1801278783 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213ES0103X | Podiatrist - Foot & Ankle Surgery | LL 1332 (Massachusetts) | Secondary |
213ES0103X | Podiatrist - Foot & Ankle Surgery | 0371 (New Hampshire) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Joseph Hospital | Nashua, NH | Hospital |
Southern Nh Medical Center | Nashua, NH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St. Joseph Hospital Of Nashua Nh | 2062455611 | 191 |
News Archive
Patients recovering from heart attacks or other heart trouble could cut their risk of another heart incident by half if they incorporate stress management into their treatment, according to research from Duke Health.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that it has entered into definitive agreements for the purchase of $50.1 million of Achillion's common stock and warrants in a private placement financing with a select group of institutional and accredited investors, namely Domain Associates, Clarus Ventures, Quaker BioVentures and Pappas Ventures.
Researchers from the University of Santiago de Compostela (USC) have analysed levels of radon, a natural radioactive gas, in 58 secondary schools in Galicia.
Edison Pharmaceuticals today announced the initiation of a phase 2 study entitled "A Phase 2 Safety and Efficacy Study of EPI-743 (Vincerinone™) in Children with Pearson Syndrome." The Investigative New Drug application (IND) was approved by the Food and Drug Administration, Office of Hematology and Oncology Products.
According to the American Stroke Association and the American Heart Association, more than 100 million Americans have high blood pressure.
› Verified 1 days ago
Provider Name | St. Joseph Hospital Of Nashua Nh |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1093787384 PECOS PAC ID: 2062455611 Enrollment ID: O20050606000515 |
News Archive
Patients recovering from heart attacks or other heart trouble could cut their risk of another heart incident by half if they incorporate stress management into their treatment, according to research from Duke Health.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that it has entered into definitive agreements for the purchase of $50.1 million of Achillion's common stock and warrants in a private placement financing with a select group of institutional and accredited investors, namely Domain Associates, Clarus Ventures, Quaker BioVentures and Pappas Ventures.
Researchers from the University of Santiago de Compostela (USC) have analysed levels of radon, a natural radioactive gas, in 58 secondary schools in Galicia.
Edison Pharmaceuticals today announced the initiation of a phase 2 study entitled "A Phase 2 Safety and Efficacy Study of EPI-743 (Vincerinone™) in Children with Pearson Syndrome." The Investigative New Drug application (IND) was approved by the Food and Drug Administration, Office of Hematology and Oncology Products.
According to the American Stroke Association and the American Heart Association, more than 100 million Americans have high blood pressure.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Michael Kelly, C/o St Marys Health System, Po Box 7291, Lewiston, ME 04243-7291 Ph: (207) 777-8695 | Michael Kelly, 166 Kinsley St Ste 201, Nashua, NH 03060 Ph: (603) 880-9177 |
News Archive
Patients recovering from heart attacks or other heart trouble could cut their risk of another heart incident by half if they incorporate stress management into their treatment, according to research from Duke Health.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that it has entered into definitive agreements for the purchase of $50.1 million of Achillion's common stock and warrants in a private placement financing with a select group of institutional and accredited investors, namely Domain Associates, Clarus Ventures, Quaker BioVentures and Pappas Ventures.
Researchers from the University of Santiago de Compostela (USC) have analysed levels of radon, a natural radioactive gas, in 58 secondary schools in Galicia.
Edison Pharmaceuticals today announced the initiation of a phase 2 study entitled "A Phase 2 Safety and Efficacy Study of EPI-743 (Vincerinone™) in Children with Pearson Syndrome." The Investigative New Drug application (IND) was approved by the Food and Drug Administration, Office of Hematology and Oncology Products.
According to the American Stroke Association and the American Heart Association, more than 100 million Americans have high blood pressure.
› Verified 1 days ago
Ankle & Foot Center Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 17 Riverside St, #205, Nashua, NH 03062 Phone: 603-882-8866 Fax: 603-882-8968 | |
Heel To Toe Podiatry Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 19 Tyler St Ste And304, Nashua, NH 03060 Phone: 617-435-0422 | |
Dr. David R. Kosofsky, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 166 Kinsley St Ste 201, Nashua, NH 03060 Phone: 603-880-9177 Fax: 603-880-9672 | |
David Duffy Court Jr., D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2300 Southwood Dr, Nashua, NH 03063 Phone: 603-577-4340 | |
Dr. Chris C. Panagoulias, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3 Water St, Suite 101, Nashua, NH 03060 Phone: 603-883-1321 Fax: 603-883-1373 | |
Ilana Itenberg, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 17 Prospect St, Nashua, NH 03060 Phone: 603-577-3230 Fax: 603-577-3234 | |
Dr. Gabriel S Hamawi, Podiatrist Medicare: Medicare Enrolled Practice Location: 17 Prospect St Ste S201, Nashua, NH 03060 Phone: 603-577-3230 Fax: 603-577-3234 |